We demonstrated cognitive deficits and brain imaging findings (i.e., thalamic T2 hypointensity, cerebral atrophy) similar to those previously published in the Finnish AGU population, suggesting loss of the AGA enzyme activity, regardless of genotype, leads to similar patterns of neurodegeneration. The gene discussed is AGA; the disease is Cerebral atrophy.